X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2025-01-31 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $176.85 | -43,902 | 70,629 | -38% | -$7,763,862 | |||||
M | 2025-01-29 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $169.12 | -6,221 | 101,811 | -6% | -$1,052,112 | |||||
M | 2025-01-29 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $167.31 | -1,217 | 349,504 | 0% | -$203,613 | |||||
2025-01-29 | NTRA | Rabinowitz Matthew | Exec COB | S - Sale | $165.87 | -6,003 | 2,467,177 | 0% | -$995,716 | ||||||
2025-01-29 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale | $165.87 | -4,773 | 213,020 | -2% | -$791,694 | ||||||
2025-01-29 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $165.87 | -5,201 | 135,483 | -4% | -$862,688 | ||||||
2025-01-29 | NTRA | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $165.87 | -4,030 | 143,200 | -3% | -$668,454 | ||||||
2025-01-29 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $165.87 | -13,685 | 253,944 | -5% | -$2,269,928 | ||||||
2025-01-27 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $161.87 | -1,442 | 108,032 | -1% | -$233,417 | ||||||
DM | 2025-01-23 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $171.67 | -1,441 | 109,474 | -1% | -$247,378 | |||||
2025-01-22 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $164.97 | -24,861 | 140,684 | -15% | -$4,101,226 | ||||||
2025-01-22 | NTRA | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $164.97 | -21,228 | 147,230 | -13% | -$3,501,905 | ||||||
D | 2025-01-22 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $165.00 | -971 | 351,309 | 0% | -$160,214 | |||||
D | 2025-01-22 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $164.97 | -22,039 | 217,793 | -9% | -$3,635,685 | |||||
D | 2025-01-22 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $164.97 | -78,553 | 267,629 | -23% | -$12,958,585 | |||||
D | 2025-01-22 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $164.97 | -25,931 | 109,665 | -19% | -$4,277,735 | |||||
2025-01-08 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale | $175.30 | -6,223 | 199,804 | -3% | -$1,090,901 | ||||||
2025-01-02 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $159.50 | -5,700 | 343,936 | -2% | -$909,126 | ||||||
2024-12-23 | NTRA | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $159.60 | -669 | 114,142 | -1% | -$106,773 | ||||||
2024-12-23 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $159.60 | -2,428 | 116,997 | -2% | -$387,511 | ||||||
2024-12-18 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $167.25 | -5,700 | 396,414 | -1% | -$953,337 | ||||||
2024-12-13 | NTRA | Rabinowitz Matthew | Exec COB | S - Sale | $165.74 | -160,000 | 2,473,180 | -6% | -$26,518,750 | ||||||
2024-12-10 | NTRA | Chapman Rowan E | Dir | S - Sale | $170.24 | -1,767 | 6,202 | -22% | -$300,808 | ||||||
D | 2024-12-09 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale+OE | $166.59 | -4,858 | 114,912 | -4% | -$809,312 | |||||
2024-12-02 | NTRA | Botha Roelof | Dir | S - Sale | $169.12 | -87,473 | 1,228,554 | -7% | -$14,793,563 | ||||||
M | 2024-11-25 | NTRA | Rabinowitz Matthew | Exec COB | S - Sale | $166.34 | -4,000 | 2,564,684 | 0% | -$665,376 | |||||
2024-11-19 | NTRA | Marcus Gail Boxer | Dir | S - Sale | $159.98 | -9,682 | 9,704 | -50% | -$1,548,931 | ||||||
D | 2024-11-15 | NTRA | Baynes Roy D. | Dir | S - Sale+OE | $146.11 | -37,230 | 15,807 | -70% | -$5,439,565 | |||||
2024-11-15 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $146.41 | -4,728 | 371,911 | -1% | -$692,209 | ||||||
2024-11-13 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $154.86 | -36,300 | 355,336 | -9% | -$5,621,396 | ||||||
2024-11-14 | NTRA | Marcus Gail Boxer | Dir | S - Sale | $158.53 | -2,212 | 19,386 | -10% | -$350,672 | ||||||
2024-11-08 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $130.78 | -5,700 | 391,636 | -1% | -$745,471 | ||||||
2024-10-31 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $126.45 | -1,866 | 68,851 | -3% | -$235,956 | ||||||
2024-10-28 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale | $118.21 | -1,057 | 206,027 | -1% | -$124,948 | ||||||
2024-10-28 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $118.21 | -1,196 | 110,695 | -1% | -$141,380 | ||||||
2024-10-28 | NTRA | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $118.21 | -929 | 113,136 | -1% | -$109,818 | ||||||
2024-10-28 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $118.21 | -3,960 | 189,762 | -2% | -$468,114 | ||||||
M | 2024-10-28 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $118.86 | -1,992 | 70,717 | -3% | -$236,772 | |||||
M | 2024-10-24 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $119.03 | -1,605 | 72,709 | -2% | -$191,037 | |||||
M | 2024-10-21 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $120.44 | -550 | 111,891 | 0% | -$66,241 | |||||
M | 2024-10-21 | NTRA | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $120.50 | -541 | 114,065 | 0% | -$65,193 | |||||
D | 2024-10-23 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $119.09 | -496 | 74,314 | -1% | -$59,068 | |||||
DM | 2024-10-21 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $120.46 | -816 | 207,084 | 0% | -$98,298 | |||||
DM | 2024-10-21 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $120.52 | -2,602 | 193,722 | -1% | -$313,597 | |||||
DM | 2024-10-21 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $120.46 | -1,062 | 73,560 | -1% | -$127,932 | |||||
2024-10-15 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $130.40 | -4,523 | 191,163 | -2% | -$589,797 | ||||||
2024-10-01 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $125.64 | -5,700 | 396,905 | -1% | -$716,137 | ||||||
2024-09-18 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $127.60 | -22,000 | 402,605 | -5% | -$2,807,237 | ||||||
2024-09-16 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $128.48 | -5,024 | 195,686 | -3% | -$645,474 | ||||||
D | 2024-09-13 | NTRA | Chapman Rowan E | Dir | S - Sale+OE | $127.68 | -2,614 | 7,969 | -25% | -$333,756 | |||||
2024-08-15 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $118.91 | -5,583 | 200,710 | -3% | -$663,895 | ||||||
2024-08-15 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $121.01 | -12,000 | 424,605 | -3% | -$1,452,125 | ||||||
2024-08-12 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $113.82 | -2,700 | 436,605 | -1% | -$307,314 | ||||||
2024-08-13 | NTRA | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $116.67 | -3,956 | 114,606 | -3% | -$461,547 | ||||||
2024-07-29 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale | $102.77 | -1,057 | 206,400 | -1% | -$108,623 | ||||||
2024-07-29 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $102.77 | -1,196 | 112,441 | -1% | -$122,908 | ||||||
D | 2024-07-29 | NTRA | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale+OE | $102.77 | -929 | 108,562 | -1% | -$95,469 | |||||
2024-07-29 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $102.77 | -4,084 | 206,293 | -2% | -$419,695 | ||||||
M | 2024-07-29 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $100.89 | -3,104 | 71,955 | -4% | -$313,171 | |||||
M | 2024-07-24 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $104.39 | -2,359 | 75,059 | -3% | -$246,264 | |||||
DM | 2024-07-22 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $105.88 | -1,558 | 77,418 | -2% | -$164,956 | |||||
2024-07-22 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $105.16 | -549 | 113,637 | 0% | -$57,733 | ||||||
2024-07-22 | NTRA | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $105.16 | -549 | 109,391 | 0% | -$57,732 | ||||||
D | 2024-07-22 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $105.16 | -2,638 | 210,377 | -1% | -$277,410 | |||||
D | 2024-07-22 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $105.16 | -815 | 207,457 | 0% | -$85,704 | |||||
2024-07-15 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $111.66 | -5,496 | 207,855 | -3% | -$613,672 | ||||||
2024-07-01 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $108.87 | -2,700 | 438,972 | -1% | -$293,945 | ||||||
D | 2024-07-01 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $108.37 | -2,723 | 206,772 | -1% | -$295,080 | |||||
D | 2024-07-01 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $108.10 | -37,500 | 213,351 | -15% | -$4,053,805 | |||||
D | 2024-07-01 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $108.37 | -4,983 | 75,059 | -6% | -$539,987 | |||||
2024-06-18 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $109.66 | -2,700 | 441,672 | -1% | -$296,080 | ||||||
2024-06-17 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $111.61 | -6,105 | 213,351 | -3% | -$681,372 | ||||||
2024-05-30 | NTRA | Marcus Gail Boxer | Dir | S - Sale | $110.17 | -2,000 | 18,634 | -10% | -$220,330 | ||||||
2024-05-28 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $109.96 | -1,647 | 114,186 | -1% | -$181,103 | ||||||
2024-05-28 | NTRA | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $109.96 | -1,438 | 109,940 | -1% | -$158,122 | ||||||
2024-05-28 | NTRA | Chapman Rowan E | Dir | S - Sale | $109.09 | -4,856 | 5,005 | -49% | -$529,728 | ||||||
2024-05-23 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $108.30 | -1,000 | 444,372 | 0% | -$108,301 | ||||||
2024-05-15 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $107.08 | -6,779 | 219,456 | -3% | -$725,911 | ||||||
D | 2024-05-10 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $104.59 | -30,000 | 204,495 | -13% | -$3,137,567 | |||||
2024-05-10 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $105.11 | -2,700 | 457,225 | -1% | -$283,794 | ||||||
2024-05-01 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $93.97 | -1,866 | 67,542 | -3% | -$175,344 | ||||||
2024-04-29 | NTRA | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $93.14 | -929 | 110,748 | -1% | -$86,526 | ||||||
2024-04-29 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $93.14 | -1,196 | 115,833 | -1% | -$111,394 | ||||||
2024-04-29 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale | $93.14 | -1,057 | 204,495 | -1% | -$98,448 | ||||||
2024-04-29 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $93.14 | -4,084 | 226,235 | -2% | -$380,378 | ||||||
2024-04-29 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $93.14 | -1,238 | 69,408 | -2% | -$115,306 | ||||||
2024-04-25 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $89.55 | -1,000 | 459,528 | 0% | -$89,550 | ||||||
M | 2024-04-24 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $91.67 | -2,393 | 70,646 | -3% | -$219,365 | |||||
D | 2024-04-23 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $91.38 | -787 | 205,552 | 0% | -$71,915 | |||||
2024-04-23 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $91.38 | -531 | 117,029 | 0% | -$48,522 | ||||||
2024-04-23 | NTRA | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $91.38 | -522 | 111,677 | 0% | -$47,700 | ||||||
D | 2024-04-23 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $91.38 | -2,552 | 230,319 | -1% | -$233,200 | |||||
D | 2024-04-23 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $91.38 | -1,523 | 73,039 | -2% | -$139,171 | |||||
2024-04-16 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $90.82 | -80,000 | 117,560 | -40% | -$7,265,651 | ||||||
2024-04-15 | NTRA | Chapman Steven Leonard | CEO, Pres | S - Sale | $93.13 | -6,816 | 227,710 | -3% | -$634,797 | ||||||
2024-04-03 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale | $92.47 | -26,700 | 460,195 | -5% | -$2,468,822 | ||||||
2024-04-02 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $92.62 | -1,378 | 70,646 | -2% | -$127,629 | ||||||
D | 2024-03-28 | NTRA | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $90.16 | -1,447 | 486,895 | 0% | -$130,456 | |||||
D | 2024-03-28 | NTRA | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $90.42 | -743 | 204,839 | 0% | -$67,179 | |||||
2024-03-28 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $90.42 | -707 | 197,560 | 0% | -$63,924 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |